Active specific immunotherapy of Hodgkin's lymphoma by an anti-idiotype vaccine against the Hodgkin-associated CD30 antigen.
Medical Clinic I, University of Cologne, Germany.
C
C
Renner
M
M
Pfreundschuh
V
V
Diehl
C
C
Pohl
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000276:immunology; D015703:Antigens, CD / Q000276:immunology*; D000951:Antigens, Neoplasm / Q000276:immunology*; D003165:Complement System Proteins / Q000276:immunology; D003602:Cytotoxicity, Immunologic; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods*; D066298:In Vitro Techniques; D017730:Ki-1 Antigen; D051379:Mice; D016513:Mice, SCID; D009368:Neoplasm Transplantation
D000888:Antibodies, Anti-Idiotypic; D015703:Antigens, CD; D000951:Antigens, Neoplasm; D017730:Ki-1 Antigen; D003165:Complement System Proteins